Drug Profile
Metformin - Shiner Pharm
Alternative Names: HENFORMIN F.C.Latest Information Update: 12 Jan 2022
Price :
$50
*
At a glance
- Originator Shiner Pharm Corp
- Class Antihyperglycaemics; Biguanides; Eye disorder therapies; Small molecules
- Mechanism of Action AMP activated protein kinase stimulants; Gluconeogenesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diabetes mellitus
Most Recent Events
- 07 Feb 2019 Chemical structure information added
- 12 Feb 2016 Launched for Diabetes mellitus in Taiwan (PO) before February 2016